CCO Conference Highlights of the ESMO 2019 Congress

September 27 - October 1, 2019; Barcelona, Spain
Download this summary slideset of the key data in breast cancer, gastrointestinal cancers, gynecologic cancers, and thoracic malignancies from the 2019 Oncology meeting in Barcelona!
Axel Grothey Headshot
Axel Grothey, MD
Sara Hurvitz, MD, FACP
Bradley J. Monk, MD, FACS, FACOG
Sandip P. Patel, MD
Format: Microsoft PowerPoint (.ppt)
File Size: 2.53 MB
Released: October 10, 2019

Acknowledgements

Supported by educational grants from
AbbVie
Agios Pharmaceuticals
Bristol-Myers Squibb
Eisai
PharmaMar

Related Content

Prof Nicole Concin, MD, PhD, shares her thoughts on the application of new clinical data for ovarian and endometrial cancers in Europe in this clinical commentary from Clinical Care Options (CCO)

Nicole Concin, MD, PhD Released: December 7, 2021

Clinical commentary with Colleen Bohnenkamp, PharmD, BCOP, BCPS, and Dane Fritzsche, PharmD, BCOP, on application of new clinical data for ovarian and endometrial cancers in Europe, from Clinical Care Options (CCO)

person default Colleen Bohnenkamp, PharmD, BCOP, BCPS person default Dane Fritzsche, PharmD, BCOP Released: December 7, 2021

In this commentary from Clinical Care Options (CCO), experts look ahead to key studies being reported at SABCS 2021 and highlight what data they are most excited to see

Joyce O'Shaughnessy, MD Sara Tolaney, MD, MPH Released: December 6, 2021

In this commentary from Clinical Care Options (CCO), Dr. David Planchard provides an overview of the status of EGFR TKI combination therapy for newly diagnosed EGFR-mutated advanced NSCLC.

David Planchard, MD, PhD Released: December 3, 2021

Leaving the CCO site

You are now leaving the CCO site. The new destination site may have different terms of use and privacy policy.

Continue